9Langtry HD,Markham A.Rabeprazole:a review of its use in acid-related gastrointestinal dieorder[J].Drugs,1999,58(4):725 -742.
10Humphries TJ,Merritt GJ.Review article:drulg interaction with agents used to treat acid-related diseases[J].Aliment Pharmacol Ther,1999,13(suppl3):18-26.
3Pharmacopoeia Commission of India.Indian pharmacopoeia[S].2010:2 037-2 038.
4Surekha Y,Venugopalaiah P,Prakash KG,et al.Design and characterization of enteric coated delayed release pellets of rabeprazole sodium[J].Research Journal of Pharmacy and Technology,2013,6(12):422.
5Khalil AA, Kabapy NF, Deraz SF, et al. Heat shock proteins in on- cology: Diagnostic biomarkers or therapeutic targets? [ J]. Bio-chim Biophys Acta,2011,16(2) : 89 -104.
6Schulze U, Hampel U, Sel S, et al. Fresh and eryopreserved amni- otic membrane secrete the trefoil factor family peptide 3 that is well known to promote wound healing [ J ]. Histochem Cell Biol, 2012, 138(2) :161 - 166.
7Guth PH, Aures D, Paulsen G. Topical aspirin plus HC1 gastric le- sions in the raf. Cytoprotective effect of prostaglandin, cimetidine and probanthine [ J ]. Gastroenterology, 1979,76 ( 1 ) : 88 - 93.
8Alison MR, Chinery R, Poulsom leads to sequential expression of R, et al. Experimental ulceration spasmolytic polypeptide, intesti- nal polypeptide, intestinal trefoil factor and transforming growth factor alpha mRNA in rat stomach [ J ]. J Pathol, 1995, 175 (4) : 405.
9Hoffmann W. TFF( trefoil factor family) peptide - triggered signals promoting mucosal restitution [ J ]. Cellular and Molecular Life Sci- ences,2005,62(24) :2932 -2938.
10Suemasu S,Tanaka K,Namba T,et al. A role for HSP70 in protec- ting against indomethacin - induced gastric lesions [ J ]. J Biol Chem, 2009,284(29) : 19705 - 19715.
